Microwave Based Hair Removal System Wednesday, Aug 17 2005
Other Laser Treatments 11:16 pm
Company Also Announces Clinical Trial Of Microwave-Based Hair Removal System
SCOTTSDALE, Ariz., Dec. 9 /PRNewswire/ — Dynamic Associates Inc. (OTC: DYAS) announced today that its Microwave Medical Corp. (MMC) subsidiary has received Institutional Review Board (IRB) approval from Independent Review Consulting Inc., located in San Anselmo, Calif., to begin Phase II clinical studies of MMC’s proprietary microwave-based hair removal system.
The company recently completed a Phase I safety study using the microwave- based hair removal system. The Phase II study will be designed to prove efficacy, and the company expects to announce one or more testing sites by year-end.
“Our preclinical studies have shown permanent hair removal,” said Rainer Marquart, Ph.D., president of MMC. “By ‘permanent’, we mean that we have witnessed complete destruction, down to the base, of nearly all hair follicles in treated areas. Except for a small number of follicles that were significantly altered, the hair follicles in the treated areas have been completely eradicated, which means that it is unlikely hair will grow back. In addition, the appearance of skin that was treated is normal, meaning there was no evidence of skin irritation or discoloration.”
The company also announced that a clinical trial of the microwave-based hair removal system will begin in Germany. The German trials will be conducted by Professor Ruzicka, M.D., head of Dermatology at the University of Dusseldorf, and will take place at his office at the University.
“After successful completion of Phase I, we look forward to beginning Phase II clinical trials, both in the United States and in Germany,” said Jan Wallace, president and chief executive officer of Dynamic Associates. “The German trials, to be conducted according to FDA guidelines, are particularly important in that there is no formal regulatory approval process for our hair removal system in Europe. This means that if the data from the studies show efficacy, we will be in a
Wallace added, “The German trial is scheduled to last approximately four months. We expect to announce details of Phase II in the United States by year-end. Further, in the near-term, we expect to announce a separate German clinical trial to prove efficacy for another medical application using our microwave technology platform, the removal of spider veins.”
The United States market for hair removal is estimated to be $1 billion per year. Currently, there are a variety of treatments available: electrolysis, depilatories, waxing, and laser-based hair removal. At this time, none of these alternatives offers cost-effective, pain-free “permanent” hair removal, and the treatments are accompanied by minor epidermal side effects, including skin rash or irritation.
Dynamic Associates is a diversified holding company now engaged in: (1) developing and acquiring microwave technologies for cosmetic and medical purposes through Microwave Medical Corp. (MMC); (2) managing the operation of “Senior Care” units for various hospitals through Genesis Health Management Corporation; and, (3) manufacturing of technologically advanced components and subsystems for the communications and aerospace industries through P&H Laboratories.
Statement Under the Private Securities Litigation Reform Act
With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product acceptance, economic, competitive, governmental, results of litigation, technological and/or other factors, which are outside the control of the Company.
SOURCE Dynamic Associates Inc.